MADISON, Wis. — Research started at the University of Wisconsin-Madison could offer a breakthrough in the fight against osteoporosis.
Current drugs can only slow the effects of osteoporosis, but a clinical trial being done at UW-Madison could bring something completely different.
A drug developed by biochemistry professor Hector Deluca, 2MD, is a Vitamin-D derivative drug that would work as a “road-patching” agent that would regenerate aging bones. The drug has been successful in rats and is now being tested in a clinical trial being run by Dr. Neil Binkley, who said the drug is at least potentially one of the most, if not the most, promising agents in the osteoporosis research pipeline.